AquaBounty Technologies Supplies Statement on FDA Process for Approving Genetically Modified Food and Animals

AquaBounty Technologies, Inc. announced that it commented on a paper published in the Food Drug Law Institute's Food and Drug Policy Forum.

According to a release, in this publication, three respected scientists with long U.S. Food and Drug Administration relationships finds the process used by the US FDA to regulate products from genetically modified animals so rigorous that it goes far beyond the legally required scientific analysis of food and environmental safety.

"AquaBounty applied for US FDA approval twenty years ago. We have complied with every regulatory requirement. The company and the US FDA have been remarkably transparent," said Ronald L. Stotish, PhD, CEO of AquaBounty. "Yet our salmon, which grows to market weight in half the time and is the most studied fish in the world, still languishes in regulatory limbo. This article describing the onerous and unworkable process helps explain why the FDA's hands have been tied by forces outside the agency's control. …

To read the full text of this article and others like it, subscribe today!

Searching…